These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5128380)

  • 1. GLC determination of new antiarrhythmic drug.
    Luders R; O'Brien P; Tishler F
    J Pharm Sci; 1971 Apr; 60(4):627-8. PubMed ID: 5128380
    [No Abstract]   [Full Text] [Related]  

  • 2. The gas chromatographic determination of imidazolines in pharmaceutical preparations.
    Boon PF; Sudds W
    J Pharm Pharmacol; 1967 Dec; 19():Suppl:88S-92S. PubMed ID: 4383861
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of SU 13197, a new antiarrhythmic agent, on atrial arrhythmias: preliminary study.
    Dreifus LS; Lim HF; Rabbino MD; Watanabe Y
    Am J Cardiol; 1968 Apr; 21(4):544-8. PubMed ID: 5645997
    [No Abstract]   [Full Text] [Related]  

  • 4. Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine.
    Kelly JG; Nimmo J; Rae R; Shanks RG; Prescott LF
    J Pharm Pharmacol; 1973 Jul; 25(7):550-3. PubMed ID: 4147052
    [No Abstract]   [Full Text] [Related]  

  • 5. Ko 1173--an effective new antiarrhythmic drug.
    Clark RA; Talbot RG; Nimmo J; Prescott LF; Julian DG
    Br Heart J; 1973 May; 35(5):558-9. PubMed ID: 4716040
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of propisomide, a new antiarrhythmic agent, in biological samples by gas chromatography with a thermionic detector.
    Necciari J; Mery D; Sales Y; Berthet D; Cautreels W
    J Chromatogr; 1985 May; 341(1):202-7. PubMed ID: 4019687
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent.
    Clark RA; Julian DG; Nimmo J; Prescott LF; Talbot R
    Br J Pharmacol; 1973 Mar; 47(3):622P-623P. PubMed ID: 4730842
    [No Abstract]   [Full Text] [Related]  

  • 8. Electron-capture GLC determination of a new antiarrhythmic agent, alpha,alpha-dimethyl-4-(alpha,alpha,beta,beta-tetrafluorophenethyl) benzylamine, in biological fluids.
    Zacchei AG; Weidner L
    J Pharm Sci; 1975 May; 64(5):814-8. PubMed ID: 1151652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
    Atarashi H; Iida K; Kou M; Hirayama Y; Gotoh M; Ino T; Katoh T; Hayakawa H
    Kokyu To Junkan; 1988 Oct; 36(10):1119-24. PubMed ID: 3247527
    [No Abstract]   [Full Text] [Related]  

  • 10. Newer antiarrhythmic drugs.
    Gupta AK; Maheshwari A; Thakur RK; Lokhandwala YY
    Indian Heart J; 2001; 53(3):354-60. PubMed ID: 11516042
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy of cardiac arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Cardiol Clin; 1983 May; 1(2):305-22. PubMed ID: 6443562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J; Zhou J; Patel C; Yan GX
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.
    Harron DW; Brogden RN; Faulds D; Fitton A
    Drugs; 1992 May; 43(5):734-59. PubMed ID: 1379150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II.
    Kieć-Kononowicz K; Byrtus H; Zejc A; Filipek B; Chevallet P
    Farmaco; 1995 May; 50(5):355-60. PubMed ID: 7626171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of new insights into mechanism of antiarrhythmic drug action.
    Meinertz T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S23-7. PubMed ID: 1279305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pharmacological agents for arrhythmias.
    Mason PK; DiMarco JP
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):588-97. PubMed ID: 19843928
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical approach to antiarrhythmic therapy in patients with ventricular arrhythmia.
    Reddy CP; Arnett JD
    J La State Med Soc; 1989 May; 141(5):45-8. PubMed ID: 2659710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.